The Proteomics of Colorectal Cancer: Identification of a Protein Signature Associated with Prognosis

被引:73
|
作者
O'Dwyer, Donna [1 ]
Ralton, Lynda D. [1 ]
O'Shea, Aisling [1 ]
Murray, Graeme I. [1 ]
机构
[1] Univ Aberdeen, Dept Pathol, Aberdeen, Scotland
来源
PLOS ONE | 2011年 / 6卷 / 11期
基金
英国生物技术与生命科学研究理事会;
关键词
POOR-PROGNOSIS; EXPRESSION; MARKERS; BIOMARKERS; THERAPY; HSP60; CYTOCHROME-P450; PREDICTION; ANNEXINS; GROWTH;
D O I
10.1371/journal.pone.0027718
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Colorectal cancer is one of the commonest types of cancer and there is requirement for the identification of prognostic biomarkers. In this study protein expression profiles have been established for colorectal cancer and normal colonic mucosa by proteomics using a combination of two dimensional gel electrophoresis with fresh frozen sections of paired Dukes B colorectal cancer and normal colorectal mucosa (n = 28), gel image analysis and high performance liquid chromatography-tandem mass spectrometry. Hierarchical cluster analysis and principal components analysis showed that the protein expression profiles of colorectal cancer and normal colonic mucosa clustered into distinct patterns of protein expression. Forty-five proteins were identified as showing at least 1.5 times increased expression in colorectal cancer and the identity of these proteins was confirmed by liquid chromatography-tandem mass spectrometry. Fifteen proteins that showed increased expression were validated by immunohistochemistry using a well characterised colorectal cancer tissue microarray containing 515 primary colorectal cancer, 224 lymph node metastasis and 50 normal colonic mucosal samples. The proteins that showed the greatest degree of overexpression in primary colorectal cancer compared with normal colonic mucosa were heat shock protein 60 (p < 0.001), S100A9 (p < 0.001) and translationally controlled tumour protein (p, 0.001). Analysis of proteins individually identified 14-3-3 beta as a prognostic biomarker (chi(2) = 6.218, p = 0.013, HR = 0.639, 95% CL 0.448-0.913). Hierarchical cluster analysis identified distinct phenotypes associated with survival and a two-protein signature consisting of 14-3-3b and aldehyde dehydrogenase 1 was identified as showing prognostic significance (chi(2) = 7.306, p = 0.007, HR = 0.504, 95% CL 0.303-0.838) and that remained independently prognostic (p = 0.01, HR = 0.416, 95% CL 0.208-0.829) in a multivariate model.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] RhoA is associated with invasion and poor prognosis in colorectal cancer
    Jeong, Dongjun
    Park, Soyoung
    Kim, Hyungjoo
    Kim, Chang-Jin
    Ahn, Tae Sung
    Bae, Sang Byung
    Kim, Han Jo
    Kim, Tae Hyun
    Im, Jungkyun
    Lee, Moon Soo
    Kwon, Hyog Young
    Baek, Moo Jun
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2016, 48 (02) : 714 - 722
  • [32] Construction of a prognostic signature associated with liver metastases for prognosis and immune response prediction in colorectal cancer
    Liu, Chang
    Lu, Zhihua
    Yan, Jun
    Xue, Dong
    He, Xiaoyu
    Huang, Wenbo
    Sun, Qi
    Zhao, Wei
    Li, Fanni
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [33] A WGCNA-based cancer-associated fibroblast risk signature in colorectal cancer for prognosis and immunotherapy response
    Lv, Yiming
    Hu, Jinhui
    Zheng, Wenqian
    Shan, Lina
    Bai, Bingjun
    Zhu, Hongbo
    Dai, Sheng
    TRANSLATIONAL CANCER RESEARCH, 2023, 12 (09) : 2256 - +
  • [34] Identification of m6A-Related Biomarkers Associated with Prognosis of Colorectal Cancer
    Zhang, Zhiyong
    Zhang, Xin
    MEDICAL SCIENCE MONITOR, 2021, 27
  • [35] The role of microRNA in metastatic colorectal cancer and its significance in cancer prognosis and treatment
    Tokarz, Paulina
    Blasiak, Janusz
    ACTA BIOCHIMICA POLONICA, 2012, 59 (04) : 467 - 474
  • [36] Identification of colorectal cancer progression-associated intestinal microbiome and predictive signature construction
    Liu, Jungang
    Huang, Xiaoliang
    Chen, Chuanbin
    Wang, Zhen
    Huang, Zigui
    Qin, Mingjian
    He, Fuhai
    Tang, Binzhe
    Long, Chenyan
    Hu, Hong
    Pan, Shuibo
    Wu, Junduan
    Tang, Weizhong
    JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)
  • [37] Molecular subtype identification and prognosis stratification by a metabolism-related gene expression signature in colorectal cancer
    Lin, Dagui
    Fan, Wenhua
    Zhang, Rongxin
    Zhao, Enen
    Li, Pansong
    Zhou, Wenhao
    Peng, Jianhong
    Li, Liren
    JOURNAL OF TRANSLATIONAL MEDICINE, 2021, 19 (01)
  • [38] Identification and validation of a metabolism-related gene signature for the prognosis of colorectal cancer: a multicenter cohort study
    Han, Ping
    Yang, Xiudeng
    Li, Lina
    Bao, Jie
    Zhang, Wenqiong
    Zai, Shubei
    Zhu, Zhaoqin
    Wu, Minle
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2022, 52 (11) : 1327 - 1336
  • [39] Immune infiltration and a ferroptosis-associated gene signature for predicting the prognosis of patients with endometrial cancer
    Yin Weijiao
    Liao Fuchun
    Chen Mengjie
    Qin Xiaoqing
    Lai Hao
    Lin Yuan
    Yao Desheng
    AGING-US, 2021, 13 (12): : 16713 - 16732
  • [40] Identification of key lncRNAs in colorectal cancer progression based on associated protein-protein interaction analysis
    Zhu, Haishan
    Yu, Jiajing
    Zhu, Haifeng
    Guo, Yusheng
    Feng, Shengjie
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2017, 15